Skip to content

Ethos Technologies, Inc. LIFE Change in receivables

Change in receivables at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.69B-11,147%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$366K+879%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$6.14M-13,538%
LQD
Liquidia CorporationLQDA
$20.06M+1,463%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.17B+24.1%
Enterprise value$1.18B
P/S6,173.4×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's change in receivables?
Ethos Technologies, Inc. (LIFE) reported change in receivables of -$396K in Q1 2026.
How has Ethos Technologies, Inc. 's change in receivables changed year-over-year?
Ethos Technologies, Inc. 's change in receivables increased by 47.1% year-over-year, from -$748K to -$396K.
What does change in receivables mean?
Change in total receivables including trade and non-trade receivables.